Recommendations for Managing Adults with Histiocytic Neoplasms: New NCCN Guidelines
That patients’ signs and symptoms are often nonspecific can lead to delays in diagnosis and treatment of histiocytic disorders, and ambiguous cases should be evaluated at centers of expertise. Although challenging, it is important that clinicians remain current with advances in the management of these disorders.
Category
  • Hematologic Malignancies
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Emerging Treatment Landscape of Targeted Therapies in Hematologic Malignancies
It is integral for nurses to have current knowledge of new targeted therapies in hematologic malignancies to understand mechanisms of actions and side effect profiles to support optimal patient outcomes.
Category
  • Hematologic Malignancies
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation